Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.400
0.00 (0.00%)
Sep 18, 2026, 4:18 PM GMT
AIM:CNSL Revenue
In the fiscal year ending March 31, 2026, Cambridge Nutritional Sciences had annual revenue of 6.98M GBP, down -16.27%. Cambridge Nutritional Sciences had revenue of 3.11M in the half year ending March 31, 2026.
Revenue
6.98M
Revenue Growth
-16.27%
P/S Ratio
0.48
Revenue / Employee
82.06K
Employees
85
Market Cap
3.33M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.98M | -1.36M | -16.27% |
| Mar 31, 2025 | 8.33M | -1.44M | -14.77% |
| Mar 31, 2024 | 9.77M | 2.23M | 29.53% |
| Mar 31, 2023 | 7.55M | -993.00K | -11.63% |
| Mar 31, 2022 | 8.54M | 1.72M | 25.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Surgical Innovations Group | 11.60M |
| Fortis Frontier | 3.22M |
| Metir | 1.44M |
| Physiomics | 1.01M |